What is Inflammatory Breast cancer?

Inflammatory breast cancer is a rare disease, accounting for 1% to 5% of all invasive breast cancers. Patients typically do not find a lump. Instead, the affected breast often becomes swollen, red and tender.

These symptoms are not caused by inflammation but by cancer cells blocking lymph vessels in the skin and soft tissue. Lymph is a clear fluid that contains tissue waste and cells that help fight infection. It travels through the body in vessels that are similar to veins. Lymph nodes are small, bean-shaped organs that link lymph vessels.

This type of Breast cancer is an aggressive disease. While its official five-year survival rate is about 40%, advances in care are helping more patients live longer. Recent studies have shown that with the right treatment, Its five-year survival rate is closer to 70% for stage III patients, and 50% to 55% for stage IV patients.

Some cases of can be passed down from one generation to the next. Genetic counseling may be right for you.

Early and accurate diagnosis and personalized treatment by experts who specialize in IBC can make an important difference.

Why choose us?

At ACH, we treat women with inflammatory breast cancer – both those who have been treated before and those who are newly diagnosed.

Our experts are highly skilled in diagnosing inflammatory breast cancer. Doctors from many disciplines work in teams to customize your treatment, and they use the most-advanced techniques and technology.

We’re still learning about It. Many recent studies show the best treatment often is based on each cancer’s specific genetic and biological makeup.

Already, our experts have found that combining computed tomography (CT) with positron emission tomography (PET) scans and magnetic resonance imaging (MRI) can more quickly and accurately find where inflammatory breast cancer has spread.